natgillin/translations-raw huggingface dataset:
Zdi se, da zdravilo Teysuno ne vpliva na plodnost samcev ali samic pri podganah, toda pri uporabi zdravila po spočetju so opazili vrsto zunanjih, visceralnih in skeletnih nenormalnosti plodov pri podganah in kuncih.
Teysuno does not appear to affect male or female fertility in the rat; however, administration at any time after conception resulted in a range of external, visceral, and skeletal foetal abnormalities in rat and rabbit.
ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI
SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
ZDRAVILA ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI
SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
Zdravila Klopidogrel Teva Pharma B.V. ne smete prenehati jemati, ne da bi se o tem prej posvetovali z zdravnikom.
Do not stop taking Clopidogrel Teva Pharma B.V. without discussing it with your doctor first.
Zdravila Meloxivet ne smemo dajati skupaj z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi.
Meloxivet must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Zdravila Meloxivet ne smete dajati:
Do not administer Meloxivet:
Zdravila ne smemo mešati z drugimi zdravili, razen tistimi, ki so omenjena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Zdravila ne smemo mešati z drugimi zdravili.
This medicinal product must not be mixed with other medicinal products.
Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
Any unused product remaining in the syringe should be thrown away.
Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
Any unused product remaining in the vial and the syringe should be thrown away.
Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
Do not throw away any medicinesvia wastewater or household waste.
Zdravila ne smete uporabljati, če je raztopina obarvana ali motna ali če so v njej vidni tuji delci.
The medicinal product should not be used if the solution is discoloured or cloudy, or if foreign particulate matter is present.
Zdravila ne uporabljajte pri psih v dobi rasti, ker lahko okvari sklepni hrustanec.
Do not use in dogs during the period of growth as articular cartilage may be affected.
Zdravila ne uporabljajte pri psih v obdobju rasti, ker ima lahko škodljiv učinek na sklepni hrustanec.
Do not use in dogs during the period of growth as articular cartilage may be affected.
Zdravila ne uporabljamo pri psih v obdobju rasti, ker ima lahko škodljiv učinek na sklepni hrustanec.
Do not use in dogs during the period of growth as articular cartilage may be affected.
Zdravila Palonosetron Hospira ni priporočljivo jemati v dneh, ki sledijo kemoterapiji, razen če prejemate naslednji ciklus kemoterapije.
It is not recommended to receive Palonosetron Hospira in the days following chemotherapy unless you are receiving another chemotherapy cycle.
Zdravila Pramipeksol Accord ne prenehajte jemati brez posveta s svojim zdravnikom.
Do not stop taking Pramipexole Accord without first talking to your doctor.
Zdravila Pramipeksol Accord ne smemo uporabiti pri otrocih in mladostnikih s Tourettovim sindromom, ker ima pri tej motnji negativno razmerje med koristjo in tveganjem (glejte poglavje 5.1).
Pramipexole Accord should not be used in children or adolescents with Tourette Disorder because of a negative benefit-risk balance for this disorder (see section 5.1).
Zdravila Pramipeksol Accord ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli poleg oznake EXP.
Do not use this medicine after the expiry date which is stated on the carton after EXP.
Zdravila Pramipeksol Accord po možnosti ne smete jemati hkrati z antipsihotiki.
You should avoid taking Pramipexole Accord together with antipsychotic medicines.
zdravila proti strjevanju krvi: kumarinske antikoagulante, kot je varfarin;
blood-thinning medicines: coumarin-derivative anticoagulants such as warfarin
Zdravila STELARA ne smete infundirati istočasno z drugimi zdravili po isti intravenski liniji.
STELARA should not be administered concomitantly in the same intravenous line with other medicinal products.
Zdravila Stelara ne smete mešati z drugimi tekočinami za injiciranje.
Do not mix Stelara with other liquids for injection
Zdravila STELARA niso preskušali pri bolnikih, ki so prejeli imunoterapijo proti alergiji.
STELARA has not been evaluated in patients who have undergone allergy immunotherapy.
Zdravila STELARA v tej skupini bolnikov niso proučevali, zato ni mogoče dati priporočil za njegovo odmerjanje.
STELARA has not been studied in these patient populations.
Zdravila Tepotekan Teva ne smete uporabiti, če so v njem vidni delci ali če je raztopina motna.
Do not use Topotecan Teva if you notice any visible particles or if the solution is unclear.
Zdravila Teysuno ne priporočajo za otroke, mlajše od 18 let.
Teysuno is not recommended for children under 18 years of age.
Zdravila Teysuno ne smete uporabiti kot nadomestek za druga peroralna zdravila s fluoropirimidinom;
Teysuno cannot be substituted for other oral fluoropyrimidine medicine.
Zdravila Teysuno se ne sme uporabljati pri otrocih ali mladostnikih, starih pod 18 let.
Therefore, Teysuno should not be administered to children or adolescents under 18 years of age.
Zdravila Teysuno se ne sme uporabljati skupaj s soruvidinom ali brivudinom oziroma znotraj štiritedenskega obdobja po zadnjem odmerku soruvidina ali brivudina.
Teysuno must not be used with sorivudine or brivudine or within 4 weeks of the last dose of sorivudine or brivudine.
Zdravila torej ne smete uporabiti, če je bilo močno stresano.
Do not use the medicine if it has been shaken strongly.
zdravila za zdravljenje epileptičnih napadov ali tremorjev, kot je fenitoin, ali zdravila, s katerimi se zdravi protin, kot je alopurinol.
medicines for the treatment of seizures or tremors such as phenytoin medicines that treat gout such as allopurinol
Zdravila Zoledronska kislina Actavis ne smete dobiti, če ste noseči.
You should not be given Zoledronic acid Actavis if you are pregnant.
Zdravila Zoledronska kislina Actavis ne smete dobiti: če ste alergični na zoledronsko kislino, kakšen drug difosfonat (skupina zdravil, v katero spada zdravilo Zoledronska kislina Actavis) ali katero koli sestavino tega zdravila (navedeno v poglavju 6). če dojite.
You should not be given Zoledronic acid Actavis: if you are allergic to zoledronic acid, another bisphosphonate (the group of substances to which Zoledronic acid Actavis belongs), or any of the other ingredients of this medicine (listed in section 6). if you are breast-feeding.
Zdravila Zoledronska kislina Actavis ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na viali in škatli poleg oznake EXP.
Do not use Zoledronic acid Actavis after the expiry date stated on the vial and carton after EXP.
Zdravila Zoledronska kislina Actavis ni priporočljivo uporabljati pri otrocih in mladostnikih, mlajših od 18 let.
Zoledronic acid Actavis is not recommended for use in adolescents and children below the age of 18 years.
Zdravila Zoledronska kislina Actavis se ne sme mešati z infuzijskimi raztopinami, ki vsebujejo kalcij ali druge dvovalentne katione, na primer z raztopino Ringerjevega laktata, in jo je treba dajati kot samostojno intravensko raztopino z ločenim infuzijskim sistemom.
Zoledronic acid Actavis must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer’s solution, and should be administered as a single intravenous solution in a separate infusion line.
Zdravila Zoledronska kislina Actavis se ne sme uporabljati med nosečnostjo.
Zoledronic acid Actavis should not be used during pregnancy.
Zdravila, ki se presnavljajo s citokromom P450
Medicinal products metabolised by cytochrome P450
Zdravilna (e) učinkovina (e)
Active substance:
Zdravilna učinkovina
Active substance(s)
Zdravilna učinkovina je palonosetron (v obliki palonosetronijevega klorida).
The active substance is palonosetron (as hydrochloride).
Zdravilna učinkovina je porfimer-natrij.
The active substance is porfimer sodium.
Zdravilna učinkovina je topotekanijev klorid.
The active substance is topotecan hydrochloride.
Zdravilna učinkovina je ustekinumab.
The active substance is ustekinumab.
Zdravilna učinkovina je zoledronska kislina.
The active substance is zoledronic acid.
Zdravilna učinkovina v Ibaflinu je ibafloksacin.
Ibaflin gel contains ibafloxacin as active ingredient.
Zdravilna učinkovina v zdravilu INOmax je dušikov oksid 400 ppm mol/mol.
The active substance in INOmax is nitric oxide 400 ppm mol/mol.
Zdravilna učinkovina v zdravilu INOmax je dušikov oksid 800 ppm mol/mol.
The active substance in INOmax is nitric oxide 800 ppm mol/mol.
Zdravilna učinkovina v zdravilu Zoledronska kislina Actavis je zoledronska kislina, ki spada v skupino snovi, imenovanih difosfonati.
The active substance in Zoledronic acid Actavis is zoledronic acid, which belongs to a group of substances called bisphosphonates.
Zdravilna učinkovina zdravila Teysuno oteracil ni vplivala na farmakokinetični profil za 5-FU, tegafur, gimeracil, FBAL ali uracil.
The oteracil component of Teysuno did not affect the pharmacokinetic profiles of 5-FU, tegafur, gimeracil, FBAL, or uracil.
Zdravilna učinkovina:
Active substance:
Zdravilne učinkovine so tegafur, gimeracil in oteracil.
The active substances are tegafur, gimeracil and oteracil.
Zdravilo
Medicinal product
Zdravilo cisplatin se ukine po šestih ciklih zdravljenja.
Cisplatin will be stopped after 6 treatment cycles.
Zdravilo dajemo le takrat, ko sta na voljo material in osebje, izkušeno v ocenjevanju in zdravljenju anafilaksije.
The medicinal product should only be administered when material and personnel experienced in evaluating and treating anaphylaxis are immediately available.
Zdravilo INOmax je na voljo v 2-litrskih in 10-litrskih aluminijastih jeklenkah.
INOmax is available in 2 litre and 10 litre aluminium gas cylinder.
Zdravilo INOmax je, skupaj s podporo dihanju in drugimi ustreznimi zdravilnimi učinkovinami, namenjeno:
INOmax, in conjunction with ventilatory support and other appropriate active substances, is indicated:
Zdravilo INOmax lahko uporabljate šele po optimizaciji podpore dihanju.
INOmax should be used only after respiratory support has been optimised.
Zdravilo INOmax se lahko dovaja samo, če ga predpiše anestezist ali zdravnik z intenzivne nege.
INOmax should only be delivered according to an anaesthetist’s or intensive care physician’s prescription.
Zdravilo INOmax se lahko uporablja šele po optimizaciji konservativne podpore.
INOmax should be used only after conservative support has been optimised.
Zdravilo INOmax se ne sme uporabljati pri nedonošenčkih, mlajših od 34 tednov nosečnosti.
INOmax should not be used in preterm baby < 34 weeks of gestational age.
Zdravilo INOmax se ne sme uporabljati v obdobju nosečnosti ali dojenja.
INOmax should not be used during pregnancy or breastfeeding.
Zdravilo INOmax se sme dovajati le, če ga predpiše neonatolog.
INOmax should only be delivered according to a neonatologist’s prescription.
Zdravilo INOmax sme uporabljati in dajati bolnikom samo osebje, ki je posebej usposobljeno za uporabo tega zdravila in ravnanje z njim.
INOmax should be used and administered only by personnel specially trained in the use and handling of INOmax.
Zdravilo INOmax sme uporabljati oz. z njim ravnati samo bolnišnično osebje.
INOmax therapy should only be used and handled by hospital personnel.
Zdravilo INOmax so varno uporabljali skupaj s tolazolinom, dopaminom, dobutaminom, steroidi, surfaktantom in pri visokofrekvenčnem predihavanju.
INOmax has been safely administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
Zdravilo INOmax uporabljajte pri predihavanju novorojenčkov, ki potrebujejo podporo >24 ur.
INOmax should be used in ventilated newborn infants expected to require support >24 hours.
Zdravilo INOmax v kombinaciji s snovmi, ki so donorji dušikovega oksida, vključno z natrijevim nitroprusidom in nitroglicerinom, lahko povzroči dodatno tveganje za razvoj methemoglobinemije.
There may be an additive effect with INOmax on the risk of developing methaemoglobinemia with nitric oxide donor substances, including sodium nitroprusside and nitroglycerin.
Zdravilo INOmax vsebuje dušik.
INOmax contains Nitrogen
Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
Do not pass it on to others.
Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
This medicine has been prescribed for you only.
Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
This medicine has been prescribed for you.
Zdravilo je potrebno z mikrobiološkega stališča uporabiti takoj.
From a microbiological point of view, the product should be used immediately.
Zdravilo Klopidogrel Teva Pharma B.V. je na voljo v perforiranih pretisnih omotih iz aluminija, ki se odlepijo, in sicer po 14x1, 28x1, 30x1, 50x1, 84x1, 90x1 ali 100x1 tablet; ter perforiranih pretisnih omotih iz aluminija, in sicer po 14x1, 28x1, 30x1, 50x1, 84x1, 90x1 ali 100x1 tablet ali v HDPE stekleničkah z zaporkami iz polipropilena, varnimi pred otroci ter silikagel sušilnim sredstvom, ki vsebujejo 30 ali 100 tablet.
Clopidogrel Teva Pharma B.V. is supplied in peelable perforated blisters of aluminium/ aluminium containing 14x1, 28x1, 30x1, 50x1, 84x1, 90x1 or 100x1 tablet; perforated blisters of aluminium/ aluminium containing 14x1, 28x1, 30x1, 50x1, 84x1, 90x1 or 100x1 tablet or HDPE bottles with polypropylene closures or child resistant polypropylene closures and silica gel desiccant containing 30 or 100 tablets.
Zdravilo Klopidogrel Teva Pharma B.V. klopidogrel in spada v skupino zdravil imenovano »zaviralci agregacije trombocitov«.
Clopidogrel Teva Pharma B.V contains clopidogrel and belongs to a group of medicines called “platelet aggregation inhibitors.”
Zdravilo Klopidogrel Teva Pharma B.V. lahko jemljete s hrano ali brez nje.
You can take Clopidogrel Teva Pharma B.V. with or without food.
Zdravilo Klopidogrel Teva Pharma B.V. s hrano in pijačo
Clopidogrel Teva Pharma B.V. with food and drink
Zdravilo Klopidogrel Teva Pharma B.V. vsebuje tudi hidrogenirano ricinusovo olje
Clopidogrel Teva Pharma B.V. contains hydrogenated castor oil.
Zdravilo lahko jemljete s hrano ali brez nje.
You can take it with or without food.
Zdravilo ne sme zmrzniti.
Do not freeze.
Zdravilo nima veā dovoljenja za promet
<DD month YYYY>
Zdravilo nima veā dovoljenja za promet
Medicinal product no longer authorised
Zdravilo Palonosetron Hospira bodo dajali kot počasno infuzijo v veno.
Palonosetron Hospira will be given as a slow infusion into a vein.
Zdravilo Palonosetron Hospira je indicirano pri odraslih za:
Palonosetron Hospira is indicated in adults for:
Zdravilo Palonosetron Hospira je potrebno injicirati v 30 sekundah.
Palonosetron Hospira should be injected over 30 seconds.
Zdravilo Palonosetron Hospira lahko povzroča omotico ali utrujenost.
Palonosetron Hospira may cause dizziness or tiredness.
Zdravilo Palonosetron Hospira se ne sme uporabljati za preprečevanje ali zdravljenje navzee in bruhanja v dneh po kemoterapiji, razen če se ne uporabi zaradi dajanja naslednje kemoterapije.
Palonosetron Hospira should not be used to prevent or treat nausea and vomiting in the days following chemotherapy if not associated with another chemotherapy administration.
Zdravilo Palonosetron Hospira se sme uporabiti samo pred dajanjem kemoterapije.
Palonosetron Hospira should be used only before chemotherapy administration.
Zdravilo Palonosetron Hospira se uporablja za preprečevanje slabosti in bruhanja pri kemoterapiji raka pri odraslih bolnikih, mladostnikih in otrocih, starejših od enega meseca.
Palonosetron Hospira is used for the prevention of nausea and vomiting associated with cancer chemotherapy in adults, adolescents and children over one month of age.
Zdravilo Palonosetron Hospira spada v skupino zdravil, znanih pod imenom antagonisti serotoninskih 5- HT3 receptorjev.
Palonosetron Hospira belongs to a group of medicines known as serotonin (5HT3) antagonists.
Zdravilo Palonosetron Hospira vsebuje manj kot 1 mmol (23 mg) natrija na vialo, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium- free’.
Zdravilo Pemetreksed Hospira 100 mg vsebuje manj kot 1 mmol (23 mg) natrija, kar v bistvu pomeni "brez natrija".
Pemetrexed Hospira 100 mg contains less than 1 mmol (23 mg) of sodium i.e. essentially ‘sodium free’.
Zdravilo Pemetreksed Hospira 500 mg vsebuje približno 54 mg natrija na vialo.
Pemetrexed Hospira 500 mg contains approximately 54 mg sodium per vial.
Zdravilo Pemetreksed Hospira boste vedno prejeli v obliki infuzije v veno.
You will always receive Pemetrexed Hospira by infusion into one of your veins.
Zdravilo Pemetreksed Hospira ima blag ali zmeren vpliv na sposobnost vožnje in upravljanja s stroji.
Pemetrexed Hospira can have a minor or moderate influence on ability to drive and use machines.
Zdravilo Pemetreksed Hospira je indicirano kot monoterapija za zdravljenje drugega izbora bolnikov z lokalno napredovalim ali metastatskim nedrobnoceličnim pljučnim karcinomom, ki nima pretežno ploščatocelične histologije (glejte poglavje 5.1).
Pemetrexed Hospira is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).
Zdravilo Pemetreksed Hospira je v kombinaciji s cisplatinom indicirano za zdravljenje bolnikov z neresektabilnim malignim plevralnim mezoteliomom, ki jih še nismo zdravili s kemoterapijo.
Pemetrexed Hospira in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.
Zdravilo Pemetreksed Hospira kot samostojno zdravilo
Pemetrexed Hospira as single agent
Zdravilo Pemetreksed Hospira se daje kot 10-minutna intravenska infuzija prvi dan vsakega 21- dnevnega ciklusa.
Pemetrexed Hospira should be administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle.
Zdravilo Pemetreksed Hospira smemo dajati le pod nadzorom zdravnika, usposobljenega za uporabo kemoterapije za zdravljenje raka.
Pemetrexed Hospira must only be administered under the supervision of a physician qualified in the use of anti-cancer chemotherapy.
Zdravilo Pemetreksed Hospira v kombinaciji s cisplatinom
Pemetrexed Hospira in combination with cisplatin
Zdravilo PhotoBarr
That PhotoBarr
Zdravilo Pramipeksol Accord ima pomemben vpliv na sposobnost vožnje in upravljanja s stroji.
Pramipexole Accord has major influence on the ability to drive and use machines.
Zdravilo Pramipeksol Accord lahko jemljete s hrano ali brez.
You can take Pramipexole Accord with or without food.
Zdravilo Pramipeksol Accord lahko jemljete s hrano ali ne.
Pramipexole Accord can be taken with or without food.
Zdravilo Pramipeksol Accord lahko povzroči halucinacije (pojav, pri katerem vidite, slišite ali čutite nekaj, česar ni).
Pramipexole Accord can cause hallucinations (seeing, hearing or feeling things that are not there).
Zdravilo Pramipeksol Accord lahko zmanjša količino mleka.
Pramipexole Accord can reduce the production of breast milk.
Zdravilo Pramipeksol Accord ni primerno za uporabo pri otrocih in mladostnikih, mlajših od 18 let, ker pri njih učinkovitost in varnost zdravila še nista dokazani.
Pramipexole Accord is not recommended for use in children and adolescents below 18 years since the efficacy and safety has not been established in this population.
Zdravilo Pramipeksol Accord so zlasti pri bolnikih s Parkinsonovo boleznijo povezovali z zaspanostjo in epizodami nepremagljivega spanca.
Pramipexole Accord has been associated with sleepiness and episodes of suddenly falling asleep, particularly in patients with Parkinson’s disease.
Zdravilo Pramipeksol Accord uporabljamo med nosečnostjo le, če potencialne koristi opravičujejo potencialno tveganje za plod.
Pramipexole Accord should not be used during pregnancy unless clearly necessary, i.e. if the potential benefit justifies the potential risk to the foetus.
Zdravilo Pramipeksol Accord uporabljamo za: zdravljenje simptomov primarne Parkinsonove bolezni pri odraslih; lahko ga uporabljamo samostojno ali v kombinaciji z levodopo (drugo zdravilo za Parkinsonovo bolezen);
It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease).
Zdravilo Pravafenix je kontraindicirano pri bolnikih z zmerno do hudo okvaro ledvic (ki je določena z očistkom kreatinina < 60 ml/min). (glejte poglavje 4.3)
Pravafenix is contraindicated in patients with moderate to severe renal impairment (defined as a creatinine clearance < 60 ml/min) (see section 4.3.)
Zdravilo Pravafenix nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Pravafenix has no or negligible influence on the ability to drive and use machines.
Zdravilo Pravafenix ponavadi ne vpliva na sposobnost upravljanja vozil in strojev.
Pravafenix does not usually affect your ability to drive or use machines.
Zdravilo Pravafenix se ne priporoča pri bolnikih z zmerno okvaro jeter, pri bolnikih s hudo okvaro jeter pa je kontraindicirano (glejte poglavje 4.3).
Pravafenix is not recommended in patients with moderate hepatic impairment and is contraindicated in patients with severe hepatic impairment (see section 4.3.).
Zdravilo Pravafenix se uporablja pri odraslih skupaj z dieto z malo maščobami za znižanje ravni „slabega“ holesterola (holesterola LDL); zdravilo to doseže tako, da zniža raven
To lower the level of your ‘bad’ cholesterol (LDL cholesterol).
Zdravilo Pravafenix skupaj s hrano, pijačo in alkoholom
Pravafenix with food, drink and alcohol
Zdravilo Pravafenix vedno vzemite skupaj s hrano, saj se na tešče slabše absorbira.
Always take Pravafenix with food as Pravafenix is less well absorbed from an empty stomach.
Zdravilo se jemlje z vodo in najmanj 1 uro pred obrokom ali 1 uro po obroku (glejte poglavje 4.2).
It should be taken with water at least 1 hour before or 1 hour after a meal (see section 4.2).
Zdravilo se pri psih lahko uporablja v obdobju brejosti.
Can be used during pregnancy in dogs.
Zdravilo shranjujte nedosegljivo otrokom!
Keep out of the sight and reach of children
Zdravilo shranjujte nedosegljivo otrokom!
Keep out of the sight and reach of children.
Zdravilo shranjujte nedosegljivo otrokom!
Keep this medicine out of the sight and reach of children
Zdravilo shranjujte nedosegljivo otrokom.
Keep out of the reach and sight of children.
Zdravilo shranjujte nedosegljivo otrokom.
Keep out of the sight and reach of children.
Zdravilo shranjujte nedosegljivo otrokom.
Keep this medicine out of the sight and reach of children.
Zdravilo shranjujte pri temperaturi do 25°C. Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
Do not store above 25°C. Store in the original package to protect from light.
Zdravilo shranjujte zunaj dosega in pogleda otrok.
Keep out of the reach and sight of children.
Zdravilo STELARA 130 mg je namenjeno le za intravensko uporabo.
STELARA 130 mg is for intravenous use only.
Zdravilo Stelara 130 mg koncentrat za raztopino za infundiranje boste prejeli v bolnišnici ali kliniki in vam ga ne bo treba shranjevati ali z njim rokovati.
Stelara 130 mg concentrate for solution for infusion is given in a hospital or clinic and patients should not need to store or handle it.
Zdravilo Stelara 130 mg koncentrat za raztopino za infundiranje vam bo dal zdravnik v obliki kapljične infuzije v eno od ven na roki (intravenska infuzija), ki bo trajala najmanj eno uro.
Stelara 130 mg concentrate for solution for infusion will be given to you by your doctor, through a drip in the vein of your arm (intravenous infusion) over at least one hour.
Zdravilo Stelara boste uporabljali pod vodstvom in nadzorom zdravnika, ki ima izkušnje z diagnostiko in zdravljenjem Crohnove bolezni.
Stelara is intended for use under the guidance and supervision of a doctor experienced in the diagnosis and treatment of Crohn’s disease.